BioSpace News Archive

The study was published in Clinical Cancer Research, a high impact, peer-reviewed medical journal.

Iradimed will release its 2017 third quarter financial results before the market opens on Monday, October 30th.

Materia has entered into a license agreement with Evonik Industries, related to olefin metathesis catalysts, following a patent infringement case between the two companies.

BioElectronics is pleased to announce the commencement of a clinical study investigating the efficacy of ActiPatch in treating chronic musculoskeletal lower back pain.

Tata Consultancy Services, a leading global IT services, consulting and business solutions organization, has launched Connected Clinical Trials (CCT), an innovative Software as a Service (SaaS) platform that enables pharmaceutical companies to significantly transform patient engagement in clinical trials and improve the efficiency and accountability of the clinical supply process.

EndoGastric Solutions today announced the presentation of data from the Transoral Incisionless Fundoplication (TIF) 2.0 procedure using the EsophyX device after hiatal hernia repair (HHR) in patients with chronic GERD symptoms.

Arbutus Biopharma and Roivant Sciences announced the closing of the issue and sale of 500,000 convertible series A preferred shares by Arbutus to Roivant for gross proceeds to Arbutus of US$50 million (Tranche 1).

The offering is expected to close on or about October 18, 2017, subject to the satisfaction of customary closing conditions.

Boston Biomedical today announced the appointment of Edgar Braendle, M.D., Ph.D., to Executive VP, Head of Research and Development and CMO.

Aprea Therapeutics announced today that the first patients were enrolled in a Phase Ib/II clinical study of APR-246 in esophageal cancer.